554 related articles for article (PubMed ID: 24929123)
41. Additional Feeding Reveals Differences in Immune Recognition and Growth of
Kwon H; Simões ML; Reynolds RA; Dimopoulos G; Smith RC
mSphere; 2021 Mar; 6(2):. PubMed ID: 33789941
[TBL] [Abstract][Full Text] [Related]
42. Plasmodium falciparum ookinetes require mosquito midgut chondroitin sulfate proteoglycans for cell invasion.
Dinglasan RR; Alaganan A; Ghosh AK; Saito A; van Kuppevelt TH; Jacobs-Lorena M
Proc Natl Acad Sci U S A; 2007 Oct; 104(40):15882-7. PubMed ID: 17873063
[TBL] [Abstract][Full Text] [Related]
43. Intervention reducing malaria parasite load in vector mosquitoes: No impact on Plasmodium falciparum extrinsic incubation period and the survival of Anopheles gambiae.
Guissou E; Da DF; Hien DFS; Yameogo KB; Yerbanga SR; Ouédraogo GA; Dabiré KR; Lefèvre T; Cohuet A
PLoS Pathog; 2023 May; 19(5):e1011084. PubMed ID: 37195964
[TBL] [Abstract][Full Text] [Related]
44. Parasite killing in malaria non-vector mosquito Anopheles culicifacies species B: implication of nitric oxide synthase upregulation.
Vijay S; Rawat M; Adak T; Dixit R; Nanda N; Srivastava H; Sharma JK; Prasad GB; Sharma A
PLoS One; 2011 Apr; 6(4):e18400. PubMed ID: 21483693
[TBL] [Abstract][Full Text] [Related]
45. Vectorial drivers of malaria transmission in Jabi Tehnan district, Amhara Regional State, Ethiopia.
Belay AK; Asale A; Sole CL; Kinya F; Yusuf AA; Torto B; Mutero CM; Tchouassi DP
Sci Rep; 2024 Jun; 14(1):13669. PubMed ID: 38871839
[TBL] [Abstract][Full Text] [Related]
46. Temperature impacts the environmental suitability for malaria transmission by Anopheles gambiae and Anopheles stephensi.
Villena OC; Ryan SJ; Murdock CC; Johnson LR
Ecology; 2022 Aug; 103(8):e3685. PubMed ID: 35315521
[TBL] [Abstract][Full Text] [Related]
47. An antibody against an Anopheles albimanus midgut myosin reduces Plasmodium berghei oocyst development.
Lecona-Valera AN; Tao D; Rodríguez MH; López T; Dinglasan RR; Rodríguez MC
Parasit Vectors; 2016 May; 9(1):274. PubMed ID: 27165123
[TBL] [Abstract][Full Text] [Related]
48. Inhibition of JNK signaling in the Asian malaria vector Anopheles stephensi extends mosquito longevity and improves resistance to Plasmodium falciparum infection.
Souvannaseng L; Hun LV; Baker H; Klyver JM; Wang B; Pakpour N; Bridgewater JM; Napoli E; Giulivi C; Riehle MA; Luckhart S
PLoS Pathog; 2018 Nov; 14(11):e1007418. PubMed ID: 30496310
[TBL] [Abstract][Full Text] [Related]
49. FBN30 in wild Anopheles gambiae functions as a pathogen recognition molecule against clinically circulating Plasmodium falciparum in malaria endemic areas in Kenya.
Niu G; Zhang G; Franca C; Cui Y; Munga S; Afrane Y; Li J
Sci Rep; 2017 Aug; 7(1):8577. PubMed ID: 28819256
[TBL] [Abstract][Full Text] [Related]
50. The surface protein Pvs25 of Plasmodium vivax ookinetes interacts with calreticulin on the midgut apical surface of the malaria vector Anopheles albimanus.
Rodríguez Mdel C; Martínez-Barnetche J; Alvarado-Delgado A; Batista C; Argotte-Ramos RS; Hernández-Martínez S; González Cerón L; Torres JA; Margos G; Rodríguez MH
Mol Biochem Parasitol; 2007 Jun; 153(2):167-77. PubMed ID: 17442413
[TBL] [Abstract][Full Text] [Related]
51. Disruption of Plasmodium falciparum development by antibodies against a conserved mosquito midgut antigen.
Dinglasan RR; Kalume DE; Kanzok SM; Ghosh AK; Muratova O; Pandey A; Jacobs-Lorena M
Proc Natl Acad Sci U S A; 2007 Aug; 104(33):13461-6. PubMed ID: 17673553
[TBL] [Abstract][Full Text] [Related]
52. An epidemiologically successful Escherichia coli sequence type modulates Plasmodium falciparum infection in the mosquito midgut.
Tchioffo MT; Abate L; Boissière A; Nsango SE; Gimonneau G; Berry A; Oswald E; Dubois D; Morlais I
Infect Genet Evol; 2016 Sep; 43():22-30. PubMed ID: 27154329
[TBL] [Abstract][Full Text] [Related]
53. The Relative Contribution of Symptomatic and Asymptomatic Plasmodium vivax and Plasmodium falciparum Infections to the Infectious Reservoir in a Low-Endemic Setting in Ethiopia.
Tadesse FG; Slater HC; Chali W; Teelen K; Lanke K; Belachew M; Menberu T; Shumie G; Shitaye G; Okell LC; Graumans W; van Gemert GJ; Kedir S; Tesfaye A; Belachew F; Abebe W; Mamo H; Sauerwein R; Balcha T; Aseffa A; Yewhalaw D; Gadisa E; Drakeley C; Bousema T
Clin Infect Dis; 2018 Jun; 66(12):1883-1891. PubMed ID: 29304258
[TBL] [Abstract][Full Text] [Related]
54. Plasmodium vivax gametocyte proteins, Pvs48/45 and Pvs47, induce transmission-reducing antibodies by DNA immunization.
Tachibana M; Suwanabun N; Kaneko O; Iriko H; Otsuki H; Sattabongkot J; Kaneko A; Herrera S; Torii M; Tsuboi T
Vaccine; 2015 Apr; 33(16):1901-8. PubMed ID: 25765968
[TBL] [Abstract][Full Text] [Related]
55. Co-infections of Plasmodium knowlesi, P. falciparum, and P. vivax among Humans and Anopheles dirus Mosquitoes, Southern Vietnam.
Marchand RP; Culleton R; Maeno Y; Quang NT; Nakazawa S
Emerg Infect Dis; 2011 Jul; 17(7):1232-9. PubMed ID: 21762577
[TBL] [Abstract][Full Text] [Related]
56. Serum antibodies induced by intranasal immunization of mice with Plasmodium vivax Pvs25 co-administered with cholera toxin completely block parasite transmission to mosquitoes.
Arakawa T; Tsuboi T; Kishimoto A; Sattabongkot J; Suwanabun N; Rungruang T; Matsumoto Y; Tsuji N; Hisaeda H; Stowers A; Shimabukuro I; Sato Y; Torii M
Vaccine; 2003 Jul; 21(23):3143-8. PubMed ID: 12804841
[TBL] [Abstract][Full Text] [Related]
57. The use of transgenic Plasmodium berghei expressing the Plasmodium vivax antigen P25 to determine the transmission-blocking activity of sera from malaria vaccine trials.
Ramjanee S; Robertson JS; Franke-Fayard B; Sinha R; Waters AP; Janse CJ; Wu Y; Blagborough AM; Saul A; Sinden RE
Vaccine; 2007 Jan; 25(5):886-94. PubMed ID: 17049690
[TBL] [Abstract][Full Text] [Related]
58. Functional Conservation of P48/45 Proteins in the Transmission Stages of
Cao Y; Hart RJ; Bansal GP; Kumar N
mBio; 2018 Sep; 9(5):. PubMed ID: 30181253
[TBL] [Abstract][Full Text] [Related]
59. Infection intensity-dependent responses of Anopheles gambiae to the African malaria parasite Plasmodium falciparum.
Mendes AM; Awono-Ambene PH; Nsango SE; Cohuet A; Fontenille D; Kafatos FC; Christophides GK; Morlais I; Vlachou D
Infect Immun; 2011 Nov; 79(11):4708-15. PubMed ID: 21844236
[TBL] [Abstract][Full Text] [Related]
60.
Molina-Cruz A; Canepa GE; Alves E Silva TL; Williams AE; Nagyal S; Yenkoidiok-Douti L; Nagata BM; Calvo E; Andersen J; Boulanger MJ; Barillas-Mury C
Proc Natl Acad Sci U S A; 2020 Feb; 117(5):2597-2605. PubMed ID: 31969456
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
